➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Baxter
Medtronic
AstraZeneca
Boehringer Ingelheim

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

ROCURONIUM BROMIDE Drug Profile


Email this page to a colleague

« Back to Dashboard

When do Rocuronium Bromide patents expire, and what generic alternatives are available?

Rocuronium Bromide is a drug marketed by Aurobindo Pharma Ltd, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Mylan Institutional, Piramal Critical, Sagent Pharms Inc, Sandoz Inc, Tamarang, Teva Pharms, and West Ward Pharm Corp. and is included in eleven NDAs.

The generic ingredient in ROCURONIUM BROMIDE is rocuronium bromide. There are eleven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the rocuronium bromide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Rocuronium Bromide

A generic version of ROCURONIUM BROMIDE was approved as rocuronium bromide by HOSPIRA on November 26th, 2008.

  Get Started Free

Drug patent expirations by year for ROCURONIUM BROMIDE
Recent Clinical Trials for ROCURONIUM BROMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ankara City Hospital BilkentN/A
Clinical Hospital Centre ZagrebN/A
Ain Shams UniversityEarly Phase 1

See all ROCURONIUM BROMIDE clinical trials

Pharmacology for ROCURONIUM BROMIDE

US Patents and Regulatory Information for ROCURONIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 206206-001 Apr 12, 2017 AP RX No No   Get Started Free   Get Started Free   Get Started Free
Tamarang ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 091115-002 Aug 27, 2012 AP RX No No   Get Started Free   Get Started Free   Get Started Free
Hospira ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 078519-001 Nov 26, 2008 AP RX No No   Get Started Free   Get Started Free   Get Started Free
Fresenius Kabi Usa ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 078651-002 Dec 29, 2008 AP RX No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Moodys
Medtronic
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.